About Staff
Ivy Chen is currently working as a legal researcher, mainly implementing biomedical-related technological legal projects, involving precision medicine, innovative biology, advanced medical products, contract development and manufacturing organization and other fields. Specializes in biotechnology, medical science and technology legal system.
．Chang Gung University, Master of Institute of Biomedical Sciences.
．Shih Chien University, Bachelor of Food and Nutritional Sciences.
．Institute for Information Industry / Science & Technology Law Institute/ Legal Researcher (Nov, 2022 - )
．Syspower Corporation / Project Manager (Sep, 2021- Nov, 2022 )
．Medical and Pharmaceutical Industry Technology and Development Center / Project Manager (Aug, 2008 –Jun, 2021 )
．Fu Jen Catholic University Faculty of Medicine / Full-time research assistant(Aug, 2004 –May, 2008 )
Thesis
．Yi-Ching Chen, Effect of GSK3 inhibitor and LiC1 on RA-induced differentiation of U937 leukemia cell. (2004).
Article
．Yi-Ching Chen, 2023 International Regulatory Trends and Developments for Continuous Manufacturing of Pharmaceuticals, Gene Online (August 31,2023)
．Yi-Ching Chen, 2023 International Regulatory Trends and Developments in Sterile Manufacturing, Gene Online (September 1,2023)
．Yi-Ching Chen, Expert Symposium on Precision Health and Innovative Application of Precision Detection (1), Gene Online (October 18,2023)
．Yi-Ching Chen, Expert Symposium on Precision Health and Innovative Application of Precision Detection (2), Gene Online (October 19,2023)
．Yi-Ching Chen, New Advanced Manufacturing Policy 2023: Point-of-Care Manufacturing, Gene Online (October 25,2023)
．Yi-Ching Chen, Trends and new policies for distributed manufacturing of pharmaceuticals in 2023, Global Bio & Investment (October 26,2023)
．Yi-Ching Chen, Through the cross-domain integration mechanism, the Institute of Science and Law of the Institute helps the industry to accelerate the convergence with the compliance of advanced medical products, CNA (November 27,2023)
．Yi-Ching Chen, EU releases biggest drug legislation reform plan in 20 years, Science and Technology Law Review, 35(11), 2-4 (2023)
．Yi-Ching Chen, In early 2024, the Netherlands released its National Science and Technology Strategy, with a focus on biotechnology and cells, Global Bio & Investment (May 24,2024)
．Yi-Ching Chen, Understanding the Legal Challenges of Advanced Healthcare Industry Operations SICC and its team of lawyers have launched professional workshops on legal issues, CNA (August 8, 2024)
．Yi-Ching Chen, In December 2023, Germany released a new strategy to help the pharmaceutical industry strengthen research and stabilize production and supply, Gene Online, biotechlaw (November 1, 2024)
．Yi-Ching Chen, BioNTech has opened an mRNA vaccine manufacturing facility in Rwanda , Gene Online, biotechlaw(November 6, 2024)
．Yi-Ching Chen, The U.S. FDA has released a Stakeholder Engagement Implementation Plan document for distributed manufacturing of pharmaceutical products, Science and Technology Law Review, 36(2), 17-19 (2024)
．Yi-Ching Chen, Overview of innovative payment systems and market access mechanisms for advanced medical products in other countries, Analysis of the Biotechnology and Pharmaceutical Industry, No.191,1-5 (2025)
Professional speech
．Yi-Ching Chen, Pharmaceutical manufacturing trends and new policies in advanced countries, Innovative Biotechnology Trends Conference (September 18,2023)
．Yi-Ching Chen, Development trends and challenges of advanced manufacturing regulations, Nucleic Acids Lead the Way, Creating a New Situation with Intelligence: 2024 Nucleic Acid Drugs and CDMO Industry Development Seminar, (September 26,2024)
．Talent Quality Management System (TTQS) Education Training Certificate
．Procurement Professional Certificate